With advances in cancer therapy, reproductive-aged women can look forward to a life post-malignancy. Fortunately, fertility preservation (FP) may provide relief from potential infertility caused by cancer or associated caustic treatments. Outcomes of FP in pre-treatment reproductive-aged women with gliomas have not been previously characterized.
Between 2007 and 2018, 10 patients undergoing FP prior to chemotherapy and/or radiation treatment for gliomas were identified at Brigham and Women’s Hospital. They were matched 3:1 to male-factor infertility patients by age ± 1 year.
Patients with gliomas had significantly lower baseline anti-Müllerian hormone levels than male-factor infertility controls (2.37 vs 5.16 ng/mL, p = 0.002, log transformed). Despite higher starting (350 vs. 240 IU, p = 0.004) and total gonadotropin doses (4270 vs. 2270 IU, p < 0.001) over a similar stimulation duration (12.1 vs. 11.1 days, p = 0.219), cancer patients had lower peak estradiol levels (1420 vs. 2245 pg/mL, p = 0.003). The total number of follicles on the day of trigger (14.1 vs. 15.6, p = 0.284), the number of oocytes retrieved (18.4 vs. 20.5, p = 0.618), and the percentage of mature oocytes (69.9 vs. 73.8%, p = 0.076) were similar between cases and controls. One patient returned for a cryopreserved embryo transfer and delivered a healthy child.
Patients undergoing FP prior to chemotherapy and/or radiation for a glioma achieve satisfactory FP outcomes and should be appropriately counseled regarding the opportunity to family-build after treatment.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
American Cancer Society (2017) Estimated number of new cases for the four major cancers by sex and age group. https://www.cancer.org. Accessed 22 Dec 2018
Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R et al (2016) American Brain Tumor Association Adolescent and Young Adult Primary and Central Nervous System Tumors Diagnosed in the United States in 2008–2012. Neuro Oncol 18(Suppl 1):i1–i50
Oberheim Bush NA, Chang S (2016) Treatment strategies for low-grade glioma in adults. J Oncol Pract 12(12):1235–1241
Waimey KE, Smith BM, Confino R, Jeruss JS, Pavone ME (2015) Understanding fertility in young female cancer patients. J Womens Health 24(10):812–818
Schmidt KT, Larsen EC, Andersen CY, Andersen AN (2010) Risk of ovarian failure and fertility preserving methods in girls and adolescents with a malignant disease. BJOG 117(2):163–174
van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M et al (2012) Premature ovarian failure and fertility in long-term survivors of Hodgkin’s lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d’Étude des Lymphomes de l’Adulte Cohort Study. J Clin Oncol 30(3):291–299
Stone JB, Kelvin JF, DeAngelis LM (2017) Fertility preservation in primary brain tumor patients. Neurooncol Pract 4(1):40–45
Stiner R (2018) Attitudes toward fertility and fertility preservation in women diagnosed with glioma. Neurooncol Pract. https://doi.org/10.1093/nop/npy036
Oktay K, Pelin Cil A, Bang H (2006) Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 86(1):70–80
Dolinko AV, Farland LV, Missmer SA, Srouji SS, Racowsky C, Ginsburg ES (2018) Responses to fertility treatment among patients with cancer: a retrospective cohort study. Fertil Res Pract 4:3
Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP (2017) Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod 32(3):568–574
Souter I, Baltagi LM, Kuleta D, Meeker JD, Petrozza JC (2011) Women, weight, and fertility: the effect of body mass index on the outcome of superovulation/intrauterine insemination cycles. Fertil Steril 95(3):1042–1047
Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ (2013) Impact of breast cancer on anti-mullerian hormone levels in young women. Breast Cancer Res Treat 137(2):571–577
Mehm AR, Steensma DP, Srouji SS, Ginsburg ES, Brady PC (2018) Fertility preservation in women with marrow failure syndromes prior to allogeneic stem cell transplantation. Am J Hematol. https://doi.org/10.1002/ajh.25130
Cakmak H, Rosen MP (2015) Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol 27(3):215–221
Robertson AD, Missmer SA, Ginsburg ES (2011) Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril 95(2):588–591
Cakmak H, Katz A, Cedars MI, Rosen MP (2013) Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 100(6):1673–1680
Hariton E, Bortoletto P, Cardozo ER, Hochberg EP, Sabatini ME (2016) The role of oncofertility clinics in facilitating access to reproductive specialists. J Patient Exp 3(4):131–136
Conflict of interest
The authors declare that they have no conflict of interest.
This study was approved by the Partners Human Research Committee (IRB #: 2014P002144). Consent from subjects was waived due to the retrospective nature of the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nordan, T., Thomas, A.M., Ginsburg, E.S. et al. Fertility preservation outcomes in women with gliomas: a retrospective case–control study. J Neurooncol (2020). https://doi.org/10.1007/s11060-020-03429-4
- Fertility preservation
- In vitro fertilization